Related Experiment Video
Updated: May 16, 2026

06:37
Immunolabelling Myofiber Degeneration in Muscle Biopsies
Published on: December 5, 2019
Recent progress in elucidating signalling proteolytic pathways in muscle wasting: potential clinical implications
C Polge1, A-E Heng2, L Combaret1
1INRA, UMR 1019, UNH, CRNH Auvergne, F-63000 Clermont-Ferrand, France; Clermont Université, Université d'Auvergne, Unité de Nutrition Humaine, BP 10448, F-63000 Clermont-Ferrand, France.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|November 15, 2012
Summary
Muscle wasting, common in illness and inactivity, increases hospital stays and mortality. Understanding its complex signaling pathways, like those involving MAFbx/Atrogin-1 and MuRF1, is key to developing new treatments.
Area of Science:
- Biochemistry
- Molecular Biology
- Physiology
Background:
- Muscle wasting (atrophy) is prevalent in disuse and various diseases, leading to extended hospitalization, increased healthcare costs, morbidity, and mortality.
- Precise characterization of signaling pathways involved in muscle atrophy is crucial for clinical relevance.
Purpose of the Study:
- To investigate the complex signaling pathways that regulate muscle-specific ubiquitin protein ligases.
- To explore the potential of targeting these pathways for therapeutic interventions in muscle wasting conditions.
Main Methods:
- Review and synthesis of recent major research papers identifying key signaling molecules.
- Analysis of pathways inducing transcription of muscle-specific ubiquitin protein ligases (MAFbx/Atrogin-1 and MuRF1).
Main Results:
- Identification of intricate signaling pathways that induce the expression of MAFbx/Atrogin-1 and MuRF1.
- Demonstration of successful targeting of these pathways in animal models of muscle wasting.
- Revelation of a complex interplay between anabolic and catabolic processes in muscle regulation.
Conclusions:
- Targeting identified signaling pathways has shown success in animal models.
- The clinical application of these strategies to limit muscle wasting in cachectic patients presents an exciting challenge.

